Author:
Lee Hye-In,Byeon Ji-Young,Kim Young-Hoon,Lee Choong-Min,Choi Chang-Ik,Jang Choon-Gon,Bae Jung-Woo,Lee Yun Jeong,Lee Seok-Yong
Funder
National Research Foundation of Korea
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference39 articles.
1. Kimura Y, Tani T, Kanbe T et al (1985) Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneimittelforschung 35:1144–1149
2. Uchikawa T, Murakami T, Furukawa H (1992) Effects of the anti-platelet agent cilostazol on peripheral vascular disease in patients with diabetes mellitus. Arzneimittelforschung 42:322–324
3. Dawson DL, Cutler BS, Meissner MH et al (1998) Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation 98:678–686
4. Pletal [label]. Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan, 2007 < http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020863s021lbl.pdf>
5. Bramer SL, Forbes WP (1999) Effect of hepatic impairment on the pharmacokinetics of a single dose of cilostazol. Clin Pharmacokinet 37:25–32
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献